abstract
-
A new 99mTc-labelled tetrazine for targeted imaging using bioorthogonal chemistry was developed and evaluated
in vivo using a trans-cyclooctene derived bisphosphonate targeting regions of high bone turnover and bone lesions.
A new 99mTc-labelled tetrazine for targeted imaging using bioorthogonal chemistry was developed and evaluated